Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Chang‑Lin Ni"'
Publikováno v:
International Journal of Molecular Medicine
Diabetic kidney disease (DKD) is one of the major microvascular complications in patients with type 1 and/or type 2 diabetes, the first cause of end-stage renal disease (ESRD) in several countries and regions. However, the pathogenesis of DKD and the
Publikováno v:
Diabetology & Metabolic Syndrome. 2015, Vol. 7 Issue 1, p1-4. 4p. 3 Charts.
Publikováno v:
Metabolism: clinical and experimental. 63(8)
Objective Liraglutide is an anti-diabetic drug and human glucagon-like peptide-1 (GLP-1) analog that primarily functions in the pancreas. However, its extra-pancreatic functions are not clear. Skeletal muscle tissue is an important determinant of blo
Autor:
Zhu Li, Gang Wang, Yan-juan Zhu, Chen-guang Li, Yun-zhao Tang, Zhen-huan Jiang, Min Yang, Chang-Lin Ni, Li-ming Chen, Wen-yan Niu
Publikováno v:
Bioscience Reports; Jun2017, Vol. 37 Issue 3, p1-7, 7p, 3 Charts, 1 Graph
Autor:
Yun-Zhao Tang, Gang Wang, Zhen-Huan Jiang, Tian-Tian Yan, Yi-Jun Chen, Min Yang, Ling-Ling Meng, Yan-Juan Zhu, Chen-Guang Li, Zhu Li, Ping Yu, Chang-Lin Ni
Publikováno v:
Diabetology & Metabolic Syndrome; 10/19/2015, Vol. 7, p1-9, 9p, 1 Diagram, 2 Charts, 3 Graphs
Publikováno v:
Metabolism: Clinical & Experimental; Aug2014, Vol. 63 Issue 8, p1022-1030, 9p